Longer depressive episode duration negatively influences HF-rTMS treatment response: a cerebellar metabolic deficiency?

Brain Imaging and Behavior

Volumn 11, Issue 1, 2017, Pages 8-16

  Wu, Guo Rong ^a,b   Baeken, Chris ^b,c,d  

^a SOUTHWEST UNIVERSITY   (China)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

18FDG PET; Cerebellum; HF rTMS; Major depressive disorder; Treatment resistance

Indexed keywords

BENZODIAZEPINE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BRAIN METABOLISM; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; GLUCOSE METABOLISM; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR DEPRESSION; MALE; METABOLIC ENCEPHALOPATHY; MIDDLE AGED; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; REMISSION; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; BRAIN; BRAIN MAPPING; DIAGNOSTIC IMAGING; METABOLISM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION;

ADULT; BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84954409840     PISSN: 19317557     EISSN: 19317565     Source Type: Journal    
DOI: 10.1007/s11682-016-9510-0     Document Type: Article

References (50)

1. Baeken, C., De Raedt, R., Van Hove, C., Clerinx, P., De Mey, J., & Bossuyt, A. (2009). HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging. CNS Spectrums, 14(8), 439–448.
2. Baeken, C., Vanderhasselt, M. A., Remue, J., Herremans, S., Vanderbruggen, N., Zeeuws, D., et al. (2013). Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients. Journal of Affective Disorders, 151(2), 625–631.
3. Baeken, C., Desmyter, S., Duprat, R., De Raedt, R., Van Denabbeele, D., Tandt, H., et al. (2014). Self-directedness: an indicator for clinical response to the HF-rTMS treatment in refractory melancholic depression. Psychiatry Research, 220(1–2), 269–274.
4. Baeken, C., Marinazzo, D., Everaert, H., Wu, G. R., Van Hove, C., Audenaert, K., et al. (2015). The impact of accelerated HF-rTMS on the subgenual anterior cingulate cortex in refractory unipolar major depression: insights from 18FDG PET brain imaging. Brain Stimulation, 8(4), 808–815.
5. Bell-McGinty, S., Butters, M. A., Meltzer, C. C., Greer, P. J., Reynolds 3rd, C. F., & Becker, J. T. (2002). Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. American Journal of Psychiatry, 159(8), 1424–1427.
6. Berman, R. M., Narasimhan, M., Sanacora, G., Miano, A. P., Hoffman, R. E., Hu, X. S., et al. (2000). A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biological Psychiatry, 47(4), 332–327.
7. Berti, V., Mosconi, L., & Pupi, A. (2014). Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging. PET Clinics, 9(2), 129–140.
8. Brakemeier, E. L., Luborzewski, A., Danker-Hopfe, H., Kathmann, N., & Bajbouj, M. (2007). Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). Journal of Psychiatric Research, 41, 395–403.
9. Brakemeier, E. L., Wilbertz, G., Rodax, S., Danker-Hopfe, H., Zinka, B., Zwanzger, P., et al. (2008). Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients. Journal of Affective Disorders, 108, 59–70.
10. Brambilla, P., Barale, F., Caverzasi, E., & Soares, J. C. (2002). Anatomical MRI findings in mood and anxiety disorders. Epidemiologia e Psichiatria Sociale, 11(2), 88–99.
11. Brett, M., Anton, J-L., Valabregue, R., Poline, J-B. (2002). Region of interest analysis using an SPM toolbox [abstract]. Presented at the Eighth international conference of functional mapping of the human brain, June 2–6, 2002, Sendai, Japan, 16(2). Available on CD-ROM in NeuroImage 2002
12. Buckner, R. L. (2013). The cerebellum and cognitive function: 25 years of insight from anatomy and neuroimaging. Neuron, 80, 807–815.
13. Carvalho, A. F., Berk, M., Hyphantis, T. N., & McIntyre, R. S. (2014). The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychotherapy and Psychosomatics, 83(2), 70–88.
14. Cohen, R. B., Boggio, P. S., & Fregni, F. (2009). Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depression and Anxiety, 26(7), 682–688.
15. de Diego-Adeliño, J., Pires, P., Gómez-Ansón, B., Serra-Blasco, M., Vives-Gilabert, Y., Puigdemont, D., et al. (2014). Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression. Psychological Medicine, 44(6), 1171–1182.
16. De Raedt, R., Vanderhasselt, M. A., & Baeken, C. (2015). Neurostimulation as an intervention for treatment resistant depression: from research on mechanisms towards targeted neurocognitive strategies. Clinical Psychology Review, 41, 61–69.
17. Ferrari, A. J., Somerville, A. J., Baxter, A. J., Norman, R., Patten, S. B., Vos, T., et al. (2013). Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychological Medicine, 43(3), 471–481.
18. George, M. S., & Post, R. M. (2011). Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. American Journal of Psychiatry, 168, 356–364.
19. Guo, W. B., Sun, X. L., Liu, L., Xu, Q., Wu, R. R., Liu, Z. N., et al. (2011). Disrupted regional homogeneity in treatment-resistant depression: a resting-state fMRI study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(5), 1297–1302.
20. Guo, W. B., Liu, F., Chen, J. D., Gao, K., Xue, Z. M., Xu, X. J., et al. (2012). Abnormal neural activity of brain regions in treatment-resistant and treatment-sensitive major depressive disorder: a resting-state fMRI study. Journal of Psychiatric Research, 46(10), 1366–1373.
21. Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social & Clinical Psychology, 6, 278–296.
22. Kimbrell, T. A., Little, J. T., Dunn, R. T., Frye, M. A., Greenberg, B. D., Wassermann, E. M., et al. (1999). Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biological Psychiatry, 46(12), 1603–1613.
23. Lefaucheur, J. P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., et al. (2014). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology, 125(11), 2150–2206.
24. Liu, F., Guo, W., Yu, D., Gao, Q., Gao, K., Xue, Z., et al. (2012). Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans. PloS One, 7(7), e40968.
25. Machino, A., Kunisato, Y., Matsumoto, T., Yoshimura, S., Ueda, K., Yamawaki, Y., et al. (2014). Possible involvement of rumination in gray matter abnormalities in persistent symptoms of major depression: an exploratory magnetic resonance imaging voxel-based morphometry study. Journal of Affective Disorders, 168, 229–235.
26. Mayberg, H. S. (2003). Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin, 65, 193–207.
27. Mayberg, H. S. (2009). Targeted electrode-based modulation of neural circuits for depression. Journal of Clinical Investigation, 119, 717–725.
28. Paillère Martinot, M. L., Galinowski, A., Ringuenet, D., Gallarda, T., Lefaucheur, J. P., Bellivier, F., et al. (2010). Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study. International Journal of Neuropsychopharmacology, 13, 45–590.
29. Palazidou, E. (2012). The neurobiology of depression. British Medical Bulletin, 101, 127–145.
30. Peleman, K., Van Schuerbeek, P., Luypaert, R., Stadnik, T., De Raedt, R., De Mey, J., et al. (2010). Using 3D-MRI to localize the dorsolateral prefrontal cortex in TMS research. World Journal of Biological Psychiatry, 11(2 Pt 2), 425–430.
31. Peng, H. J., Zheng, H. R., Ning, Y. P., Zhang, Y., Shan, B. C., Zhang, L., et al. (2013). Abnormalities of cortical-limbic-cerebellar white matter networks may contribute to treatment-resistant depression: a diffusion tensor imaging study. BMC Psychiatry, 13, 72.
32. Perugi, G., Medda, P., Zanello, S., Toni, C., & Cassano, G. B. (2012). Episode length and mixed features as predictors of ECT nonresponse in patients with medication-resistant major depression. Brain Stimulation, 5(1), 18–24.
33. Phillips, J. R., Hewedi, D. H., Eissa, A. M., & Moustafa, A. A. (2015). The cerebellum and psychiatric disorders. Frontiers in Public Health, 3, 66.
34. Richieri, R., Boyer, L., Farisse, J., Colavolpe, C., Mundler, O., Lancon, C., et al. (2011). Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression. European Journal of Nuclear Medicine and Molecular Imaging, 38(9), 1715–1722.
35. Richieri, R., Boyer, L., Faget-Agius, C., Farisse, J., Mundler, O., Lançon, C., et al. (2015). Determinants of brain SPECT perfusion and connectivity in treatment-resistant depression. Psychiatry Research, 231(2), 134–140.
36. Rush, A. J., Thase, M. E., & Dubé, S. (2003). Research issues in the study of difficult-to-treat depression. Biological Psychiatry, 53, 743–753.
37. Schmahmann, J. D., & Pandya, D. N. (2008). Disconnection syndromes of basal ganglia, thalamus, and cerebrocerebellar systems. Cortex, 44, 1037–1066.
38. Schutter, D. J. (2009). Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychological Medicine, 39(1), 65–75.
39. Serra-Blasco, M., Portella, M. J., Gómez-Ansón, B., de Diego-Adeliño, J., Vives-Gilabert, Y., Puigdemont, D., et al. (2013). Effects of illness duration and treatment resistance on grey matter abnormalities in major depression. British Journal of Psychiatry, 202, 434–440.
40. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., et al. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 20, 22–57.
41. Speer, A. M., Benson, B. E., Kimbrell, T. K., Wassermann, E. M., Willis, M. W., Herscovitch, P., et al. (2009). Opposite effects of high and low frequency rTMS on mood in depressed patients: relationship to baseline cerebral activity on PET. Journal of Affective Disorders, 115(3), 386–394.
42. Stoodley, C. J., & Schmahmann, J. D. (2010). Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing. Cortex, 46, 831–844.
43. Su, L., Cai, Y., Xu, Y., Dutt, A., Shi, S., & Bramon, E. (2014). Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies. BMC Psychiatry, 14, 321.
44. Trevino, K., McClintock, S. M., McDonald Fischer, N., Vora, A., & Husain, M. M. (2014). Defining treatment-resistant depression: a comprehensive review of the literature. Annals of Clinical Psychiatry, 26(3), 222–232.
45. Van Overwalle, F., D'aes, T., & Mariën, P. (2016). Social cognition and the cerebellum: a meta-analytic connectivity analysis. Human Brain Mapping. doi:10.1002/hbm.23002.
46. van Randenborgh, A., Hüffmeier, J., Victor, D., Klocke, K., Borlinghaus, J., & Pawelzik, M. (2012). Contrasting chronic with episodic depression: an analysis of distorted socio-emotional information processing in chronic depression. Journal of Affective Disorders, 141(2–3), 177–184.
47. Van Strien, J. W. (2001). Handvoorkeur en taaldominantie. Neuropraxis, 2, 10–15.
48. Videbech, P., Ravnkilde, B., Pedersen, T. H., Hartvig, H., Egander, A., Clemmensen, K., et al. (2002). The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatrica Scandinavica, 106(1), 35–44.
49. Vieta, E., & Colom, F. (2011). Therapeutic options in treatment-resistant depression. Annals of Medicine, 43(7), 512–530.
50. Yoshizawa, H., Gazes, Y., Stern, Y., Miyata, Y., & Uchiyama, S. (2014). Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve. Psychiatry Research, 221(1), 78–85.